
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy is expected to see positive growth in the coming years due to the expanding hospital partnerships, M&A activity, and opening of new clinics. In the first quarter of 2026, the company exceeded revenue expectations and saw a 1.1% increase in salary and related expenses, which is impressive in the current inflationary climate. The industrial injury prevention segment continues to show strong growth, and the company is well-positioned for future expansion through its low debt levels and pursuit of external growth opportunities.
Bears say
US Physical Therapy is facing several challenges, including a missed first quarter result in terms of adjusted EPS, adjusted EBITDA, and cash flows, and concerns over clinician wage pressure as well as Medicare reimbursement pressure. Additionally, the company's exposure to economic contraction, which could decrease demand for their services, and reliance on revenue from industrial injury prevention services for manufacturing customers could negatively impact growth. Furthermore, while they have partnerships with hospital systems, the impact of these partnerships may not be fully realized until 2027. With a recent decline in the company's stock price and a reduction in their price target, it is clear that their profitability estimates have been adjusted and there are uncertainties surrounding the company's future.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares